Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06179654 · ClinicalTrials.gov registry record · NA
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
A NA study of Lower Urinary Tract Symptoms and Urinary Retention, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06179654: Recruiting NA study of Lower Urinary Tract Symptoms and Urinary Retention, sponsored by The Cleveland Clinic.
NCT06179654 is a NA study of Lower Urinary Tract Symptoms and Urinary Retention that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 36 participants, below the 749-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06179654, a NA study of Lower Urinary Tract Symptoms and Urinary Retention, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to allow us to assess the effectiveness (or success) of starting pelvic floor physical therapy (i.e. exercises for your pelvic muscles) prior to HoLEP (holmium laser enucleation of the prostate) surgery for enlarged prostates in order to manage or prevent urinary incontinence (i.e. leaking) after surgery (i.e. post-operatively). Your pelvic floor refers to the muscles under your bladder along your pelvic bones that prevent you from leaking urine or stool. Traditionally, pelvic floor physical therapy is started after surgery and continued until urinary continence (i.e. no leaking of urine) is regained. We want to assess if beginning pelvic floor physical therapy prior to surgery (and continuing afterwards) reduces the time required to regain urinary continence following HoLEP.
Primary Outcome
Time to recover from transient postoperative stress urinary incontinence
Conditions Studied
Interventions
- BEHAVIORAL Preoperative pelvic floor physical therapy
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-11-29 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT06179654 shows while recruiting
NCT06179654 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 749-participant average among 21 other Lower Urinary Tract Symptoms trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Lower Urinary Tract Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Preoperative pelvic floor physical therapy is the first listed.
NCT06179654 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06179654 about?
NCT06179654 is a clinical study titled "Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate". The purpose of this study is to allow us to assess the effectiveness (or success) of starting pelvic floor physical therapy (i.e. exercises for your pelvic muscles) prior to HoLEP (holmium laser enucleation of the prostate) surgery for enlarged prostates in order to manage or prevent urinary inconti...
What is the current status of trial NCT06179654?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-11-29. Estimated completion is 2026-10-31.
What conditions does trial NCT06179654 study?
This clinical trial studies the following conditions: Lower Urinary Tract Symptoms, Urinary Retention, Benign Prostatic Hyperplasia With Outflow Obstruction.
What interventions are being tested in trial NCT06179654?
The interventions under investigation include: Preoperative pelvic floor physical therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06179654?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06179654 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lower Urinary Tract Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06179654's enrollment target sits among peer trials
36 17th of 21 higher than 5 of 21 other Lower Urinary Tract Symptoms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lower Urinary Tract Symptoms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
PRescription Exercise for Older Men With Urinary Disease
RECRUITING · NA
-
Use of Artificial Intelligence by Urogynecologic Patients
ACTIVE NOT RECRUITING · NA
-
INTIBIA Pivotal Study
ACTIVE NOT RECRUITING · NA
-
Urological Biofeedback Game Software
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI